MILLA, Paola
 Distribuzione geografica
Continente #
EU - Europa 7.950
NA - Nord America 4.809
AS - Asia 1.472
SA - Sud America 56
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 14
Totale 14.358
Nazione #
IT - Italia 4.965
US - Stati Uniti d'America 4.715
CN - Cina 774
IE - Irlanda 561
FR - Francia 501
SE - Svezia 447
DE - Germania 334
FI - Finlandia 270
KR - Corea 263
UA - Ucraina 210
PL - Polonia 160
GB - Regno Unito 157
JP - Giappone 140
VN - Vietnam 93
AT - Austria 79
IN - India 78
CA - Canada 68
BE - Belgio 65
ES - Italia 47
CH - Svizzera 45
SN - Senegal 27
NL - Olanda 26
RO - Romania 25
TR - Turchia 23
MX - Messico 22
BR - Brasile 20
IL - Israele 18
IR - Iran 18
CO - Colombia 14
RU - Federazione Russa 14
EU - Europa 13
TH - Thailandia 13
AU - Australia 12
HK - Hong Kong 7
PT - Portogallo 7
SG - Singapore 7
DK - Danimarca 6
EC - Ecuador 6
EG - Egitto 6
MY - Malesia 6
CZ - Repubblica Ceca 5
PE - Perù 5
PY - Paraguay 5
SA - Arabia Saudita 5
ID - Indonesia 4
LT - Lituania 4
NG - Nigeria 4
TW - Taiwan 4
UZ - Uzbekistan 4
AR - Argentina 3
CL - Cile 3
GR - Grecia 3
PH - Filippine 3
SM - San Marino 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
CY - Cipro 2
HR - Croazia 2
JO - Giordania 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
HU - Ungheria 1
IQ - Iraq 1
MC - Monaco 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
SC - Seychelles 1
Totale 14.358
Città #
Chandler 656
Dublin 538
Beijing 532
Houston 250
Fairfield 242
Ann Arbor 238
Torino 201
Milan 196
Villeurbanne 196
Rome 190
Medford 166
Dearborn 163
Princeton 161
Ashburn 159
Jacksonville 149
Warsaw 125
Wilmington 121
Woodbridge 102
Pisa 94
Nyköping 90
Seattle 90
Cambridge 76
Vienna 74
Redwood City 68
Boardman 60
Dong Ket 60
Boston 53
Brussels 52
Napoli 48
Naples 43
Turin 42
Munich 35
Palermo 32
Verona 32
Catania 30
Hangzhou 28
New York 28
Florence 27
Toronto 27
Bologna 26
Dallas 26
Genova 26
Fremont 24
Des Moines 22
Mountain View 22
Padova 22
Bari 19
Düsseldorf 19
Hefei 19
Nanjing 19
Brescia 18
Seongnam 18
Shanghai 18
Menlo Park 17
Erlangen 15
Norwalk 15
Ottawa 15
Duncan 14
Washington 14
Monza 13
Trieste 13
Messina 12
Parma 12
Vicenza 12
Durham 11
Glendale 11
Guangzhou 11
Missaglia 11
Pescara 11
San Diego 11
Falls Church 10
Kunming 10
Massa 10
Phoenix 10
Piemonte 10
Pune 10
Seoul 10
Trento 10
Brindisi 9
Buffalo 9
Cagliari 9
Fuzhou 9
Genoa 9
Segrate 9
Valencia 9
Venezia 9
Andover 8
Bangkok 8
Chengdu 8
Cinisello Balsamo 8
Como 8
Custonaci 8
Frankfurt am Main 8
Nanchang 8
Paris 8
Philadelphia 8
Zurich 8
Caserta 7
Castelnuovo Rangone 7
Catanzaro 7
Totale 6.251
Nome #
Somministrazione intravescicale di Mitomicina C in ipertermia nei carcinomi vescicali superficiali a rischio intermedio 3.313
L'alcol etilico nei farmaci chemioterapici antiblastici iniettabili: valutazioni ed implicazioni pratiche 1.590
Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I–II study 353
Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients 315
Pharmacokinetic study to optimize the intravesical administration of gemcitabine 264
PEGylation of proteins and liposomes, a powerful and flexible strategy to improve the drug delivery 252
Validation of a simple and economic HPLC-UV method for the simultaneous determination of vancomycin, meropenem, piperacillin and tazobactam in plasma samples 247
Antibiotic adjustment in CRRT 235
Farmacocinetica del paclitaxel in associazione con acido valproico nella terapia del tumore anaplastico della tiroide 199
Adherence to oral chemotherapy: Evidence from a randomised clinical trial 172
Messa a punto del metodo di estrazione e determinazione analitica, tramite HPLC, dell'amfotericina B su campioni ematici 169
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial 159
Chemical and microbiological stability, anticoagulant efficacy and toxicity of 35 and 90 mM trisodium citrate solutions stored in plastic syringes 152
Dual Constant Domain-Fab: A novel strategy to improve half-life and potency of a Met therapeutic antibody 148
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae 145
Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives. 144
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 144
Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies 141
A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine 140
Vaccini, sieri, immunoglobuline e anticorpi monoclonali 123
Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms 123
Targeted Cancer Therapy: The Roles Played by Antibody-Drug and Antibody-Toxin Conjugates 115
Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment 104
Alternate scheduling of Gemcitabine (GEM) - Oxaliplatin (OXA) association in metastatic (MTS) or locally advanced (LA) pancreatic adenocarcinoma: a clinical and pharmacokinetic (pk) evaluation 97
Fenil vinil solfuri e metil vinil solfuri, inibitori specifici della ossidosqualene ciclasi di Trypanosoma cruzi e di S. cerevisiae. 96
Farmacocinetica della Gemcitabina (GEM) e del suo trifosfato (dFdCTP) in infusione prolungata a basse dosi in monochemioterapia in pazienti affetti da tumori solidi 96
A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. 95
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases 91
I medicinali senza obbligo di prescrizione in Pediatria. Tra raccomandazioni e automedicazione 90
A pharmacokinetics study to optimize intravesical administration of gemcitabine 87
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY, SAFETY AND ACTIVITY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE (UNITHERMIA) 84
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 80
Anti-TNF-α drugs: pharmacoeconomic analysis and proper use in pharmacological treatment in rheumatoid arthritis 78
19-azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae 76
Farmacocinetica dell’associazione di vinorelbina orale con doxorubicina liposomiale peghilata nel tumore mammario metastatico 76
Farmacocinetica della somministrazione alternata della Gemcitabina (GEM) e Oxaliplatino (OXA) nei tumori pancreatici e delle vie biliari 74
Yeast Oxidosqualene cyclase (Erg7p) Is a Major Component of Lipid Particles. J. Biol. Chem. (2002) 277, 2406-2412. 73
Vinyl sulfide derivatives of oxidosqualene, as inhibitors of oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae. 73
Pharmacokinetics, Pharmacological Stability, Safety and Efficacy of MMC Administered with a New Hyperthermia Device 73
Coagulation Factor VIII: pharmacoeconomic evaluation and quality of life as measuring tools in clinical practice 71
Yeast Oxidosqualene cyclase (Erg7p) Is a Major Component of Lipid Particles 70
Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate 70
Design of specific tools to evaluate the Cost Of Illness (COI) of Rheumatoid Arthritis 69
Association of Gemcitabine (GEM) and Oxaliplatin (OXA) in metastatic or locally advanced pancreatic adenocarcinoma: a clinical and pharmacokinetic (PK) study 68
Paclitaxel e doxorubicina liposomiale peghilata in tumori testa/collo recidivanti: un’inaspettata interazione farmacocinetica intervallo-dipendente relativa alla somministrazione 68
Subcellular localization of yeast oxidosqualene cyclase and other eukaryotic oxidosqualene cyclases expressed in yeast 67
Studio Farmacocinetico per determinare la modalità di somministrazione più idonea per la gemcitabina endovescicale 67
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery. 66
Administration of reduced glutathione in FOLFOX4 regimen in advanced colorectal cancer: effect on oxaliplatin pharmacokinetics and on Pt-DNA adducts formation 66
Synthesis and biological activity of aryldithio and maleimido squalene derivatives as new irreversible inhibitors of squalene 2,3-oxide-lanosterol cyclase. 65
polyclonal antibodies against a fragment of oxidosqualene cyclase(erg7p) overexpressed in E.coli recognize the enzyme of different sources 64
Studio farmacocinetico del Paclitaxel in associazione con acido valproico nella terapia del tumore anaplastico della tiroide 64
The 3-keto reductase protein (Erg27p) is required for oxidosqualene cyclase (Erg7p) activity in yeast 64
Thiol-modifying agents as tools for understanding the function of squalene cyclase 64
An independent study about over the counter medicines to analyse parents’ awareness for paediatric use 64
Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA: cholesterol O-acyltransferase inhibitors 63
Thiol-modifying Inhibitors for Understanding Squalene Cyclase Function. Eur. J. Biochem. (2002) 269, 2108-2116. 63
Economic evaluation of different modalities of immunoglobulin therapy in chronic dysimmune polyradiculoneuropathies 63
Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response 63
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY AND SAFETY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE 62
Systematic analysis of yeast strains with possible defects in lipid metabolism 61
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide. 61
Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity. 61
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors. 60
3-carboxy-4-nitrophenyl-dithio-1,1'-2-trisnorsqualene: a site directed inactivator of yeast oxidosqualene cyclase 60
Preparation and characterization of novel PEG-paclitaxel derivatives 60
Herbal Medicines in Children: between advice-giving and self-medication 60
Comparative properties of N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester and N-ethoxycarbonyl-D-phenylalanyl-alpha-azaprolyl-L-lysine p-nitrophenyl ester as subsrates of serine proteinases 58
Yeast oxidosqualene cyclase (Erg7p) is a major component of lipid particles 57
Active site titration of bovine beta-trypsin by N alpha-(N,N-dimethylcarbamoyl)-alpha-aza-lysine p-nitrophenyl ester: kinetic and crystallographic analysis 56
Ottimizzazione della somministrazione endovescicale di gemcitabina: uno studio farmacocinetico 55
Subcellular localization of oxidosqualene cyclases from Arabidopsis thaliana, Trypanosoma cruzi and Pneumocystis carinii expressed in yeast 55
The effect of five different administration intervals on the pharmacokinetics (pk) of paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) association regimen 54
Studio farmacocinetico e tossicologico dell’effetto neuroprotettivo del glutatione ridotto sulla chemioterapia basata sull’oxaliplatino nel carcinoma colon-rettale avanzato 53
Self-Assembled Squalene-based Fluorescent Heteronanoparticles 53
Stereospecific inhibition of sterol biosynthesis in HEP G2 and Saccharomyces cerevisiae cell cultures by 29-methylidene-oxidosqualene derivatives. 52
Evidence of the existence of an essential thiol group within the active site of oxidosqualene cyclase from Saccharomyces cerevisiae 52
Sterospecific irreversible inhibitors of liver and yeast oxidosqualene cyclase 52
Study of sequence-dependent pharmacokinetic interactions between oral vinorelbine (VNR) and pegylated liposomal doxorubicin (PLD) in metastatic ovarian carcinoma 52
Studio farmacocinetico dell’associazione di vinorelbina (VNR) per via orale con doxorubicina liposomale peghilata (PLD) nel carcinoma mammario metastatico 51
Effect of proteases on microsomal oxidosqualene cyclases from Saccharomyces cerevisiae and Candida albicans 51
Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: a kinetic, thermodynamic and X-ray crystallographic study 51
Stereospecific synthesis of trans-vinyl dioxidosqualene and b-hydrosulfide derivatives, as potent and time-dependent 2,3-oxidosqualene cyclase inhibitors 50
The impact of five different administration intervals on the pharmacokinetics (PK) of paclitaxel (PTX) and pegylated liposomal doxorubicin (PLD) combination 50
In vitro metabolic fate of D2-thiazoline ring: evidence for the formation of a reactive metabolite in enzymatic-dependent D2-thiazoline ring cleavage 50
Synthesis and biological activity of new iodoacetamide derivatives on mutants of squalene-hopene cyclase 50
Conjugated Methyl Sulfide and phenyl Sulfide Derivatives of Oxidosqualene as Inhibitors of Oxidosqualene and Squalene-Hopene Cyclases. 49
Synthesis and in vitro evaluation of new 4,5-diphenylthiazole derivatives as acyl-CoA:cholesterol O-acyl transferase inhibitors 49
Effects of reduced glutathione (GSH) on oxaliplatin (OXA) in advanced colorectal cancer treated by FOLFOX4 regimen: Pharmacokinetics (PK) and determination of PtDNA adducts 48
Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC ® 2 Membrane in Patients with Septic Shock 48
Squalene- and nonsqualene-like thiol modifying agents as tools for understanding the function of squalene-hopene cyclase 47
Topology of DNA: when manipulation supports the lack of “space-filling” imagination 46
Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape 46
Subcellular distribution and selective inhibition of oxidosqualene cyclases of Trypanosoma cruzi and Pneumocystis carinii expressed in Saccharomyces cerevisiae 45
Radiofarmaci 44
Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: Clinical and unexpected pharmacokinetic interactions 43
Paclitaxel and pegylated liposomal doxorubicin in recurrent head/neck cancer: clinical and pharmacokinetic preliminary data 43
Pharmacokinetic (PK) evaluation of 2’,2’-Difluorodeoxycytidine-5’-triphosphate (dFdCTP) and gemcitabine (GEM) as prolonged infusion in monochemotherapy in patients affected by solid tumors 41
Farmacocinetica delle antracicline liposomiali 41
Sulfide derivatives of oxidosqualene inhibitors of 2,3-oxidosqualene and squalene-hopene cyclase as antifungals or hypocholesterolemics. 40
Totale 13.522
Categoria #
all - tutte 30.034
article - articoli 0
book - libri 0
conference - conferenze 13.933
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019824 0 0 0 0 0 0 0 0 131 167 320 206
2019/20202.323 232 188 213 218 173 326 211 124 154 150 172 162
2020/20212.365 255 139 154 179 270 155 203 127 260 218 172 233
2021/20221.828 95 97 91 115 137 109 117 136 62 101 376 392
2022/20232.696 273 162 124 260 247 556 287 163 251 106 159 108
2023/2024971 151 215 119 102 87 138 62 82 15 0 0 0
Totale 14.867